Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 5/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 5/20 | 0.30 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | GMNN | O75496 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | TP53 | P04637 | 2/20 | 0.30 |
| ▸ | POLB | P06746 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | APEX1 | P27695 | 2/20 | 0.30 |
| ▸ | THPO | P40225 | 2/20 | 0.30 |
| ▸ | RECQL | P46063 | 2/20 | 0.30 |
| ▸ | BLM | P54132 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12201294 | 0.88 | LIPG (0.47) | LIPGACHEBCHEENPP2MEN1 | |
| SCHEMBL14601221 | 0.85 | LIPG (0.32) | LIPG | |
| SCHEMBL12201301 | 0.80 | ATM (0.50) | LIPGACHEBCHEENPP2MEN1 | |
| SCHEMBL14601222 | 0.73 | LIPG (0.36) | LIPGENPP2 | |
| SCHEMBL39286 | 0.73 | LIPE (0.38) | LIPGACHEBCHEENPP2 | |
| SCHEMBL19422741 | 0.72 | ACHE (0.67) | ACHEBCHEMEN1LMNAKMT2A | |
| SCHEMBL12972595 | 0.72 | LIPG (0.46) | LIPGACHEBCHEENPP2ALDH1A1 | |
| SCHEMBL17558809 | 0.70 | BCHE (0.44) | LIPGACHEMAPTBCHEENPP2 | |
| SCHEMBL29377890 | 0.69 | LIPG (0.55) | LIPGMAPTENPP2TSHR | |
| SCHEMBL8530 | 0.69 | LIPG (0.55) | LIPGMAPTENPP2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8338602-B2 | Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (US) | 2012-12-25 | — | — | US | disclosed |
| US-8034633-B2 | Microwave accelerated assays | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (US) | 2011-10-11 | — | — | US | disclosed |
| US-7939333-B2 | Metal enhanced fluorescence-based sensing methods | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (US) | 2011-05-10 | — | — | US | disclosed |
| US-20100297016-A1 | QUARTERNARY NITROGEN HETEROCYCLIC COMPOUNDS FOR DETECTING AQUEOUS MONOSACCHARIDES IN PHYSIOLOGICAL FLUIDS | GEDDES, CHRIS, DR. | 2010-11-25 | — | — | US | disclosed |
| US-7732215-B2 | Cyanide sensing compounds and uses thereof | UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) | 2010-06-08 | — | — | US | disclosed |
| US-7718804-B2 | Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids | UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) | 2010-05-18 | — | — | US | disclosed |
| US-20100028983-A1 | MICROWAVE ACCELERATED ASSAYS | UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) | 2010-02-04 | — | — | US | disclosed |
| US-20090142847-A1 | METAL ENHANCED FLUORESCENCE-BASED SENSING METHODS | UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) | 2009-06-04 | — | — | US | disclosed |
| US-20080096281-A1 | Cyanide Sensing Compounds and Uses Thereof | GEDDES, CHRIS, DR. | 2008-04-24 | — | — | US | disclosed |
| US-20070020182-A1 | Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids | GEDDES, CHRIS, DR. | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100297016-A1 | QUARTERNARY NITROGEN HETEROCYCLIC COMPOUNDS FOR DETECTING AQUEOUS MONOSACCHARIDES IN PHYSIOLOGICAL FLUIDS | SLC5A1, NISCH, SLC5A2 | LIPG 1521/4885ACHE 1414/4885MAPT 2761/4885 |
| US-20070020182-A1 | Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids | SLC5A1, NISCH, SLC5A2 | LIPG 1713/4885ACHE 1048/4885MAPT 2460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.